Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter
about
Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeabilityIntestinal permeability regulation by tight junction: implication on inflammatory bowel diseasesConceptual barriers to understanding physical barriersClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetAmelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathwayEpithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.Role of myosin light chain kinase in intestinal epithelial barrier defects in a rat model of bowel obstruction.Crystallization and preliminary X-ray analysis of the human long myosin light-chain kinase 1-specific domain IgCAM3.Pentoxifylline modulates intestinal tight junction signaling after burn injury: effects on myosin light chain kinase.Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis.Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application.Inflammatory bowel disease: is it really just another break in the wall?Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation.Myosin light chain kinase: pulling the strings of epithelial tight junction functionMechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.Inhibition of long myosin light-chain kinase activation alleviates intestinal damage after binge ethanol exposure and burn injuryIn Vivo and In Vitro Antinociceptive Effect of Fagopyrum cymosum (Trev.) Meisn Extracts: A Possible Action by Recovering Intestinal Barrier DysfunctionStimulus-induced reorganization of tight junction structure: the role of membrane trafficBeyond Ussing's chambers: contemporary thoughts on integration of transepithelial transport.Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: involvement of β1 integrins.Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationConditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB.LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.Cytokine regulation of tight junctionsThe tight junction in inflammatory disease: communication breakdown.Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.Mechanisms and functional implications of intestinal barrier defects.Protective Effects of the Segmental Renal Artery Clamping Technique on Ischemia-Reperfusion Injury in db/db Diabetic MiceImportance of disrupted intestinal barrier in inflammatory bowel diseases.Bacteria and host interactions in the gut epithelial barrier.Protein kinases are potential targets to treat inflammatory bowel disease.Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability.TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism.The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function in health and disease.The intestinal epithelial barrier: a therapeutic target?Claudin-2 regulates colorectal inflammation via myosin light chain kinase-dependent signaling.From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.Involvement of HIF-1α in MLCK-dependent endothelial barrier dysfunction in hypoxia.GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability.
P2860
Q24317362-214CFF2F-A036-449B-AFEB-F6F42766348FQ26859272-A71BBC19-4C2F-47F1-ACDA-58E567EED34DQ26861369-BF714BA3-E4F6-44FB-A4CB-8831A59F1CFBQ28066092-2A42470A-A435-41DB-A7FF-0B8292B1996FQ28487645-BC1E97FE-72C7-4A99-AF54-40A38AE64092Q33556277-40EEBDF9-BF7B-41C0-BC35-301BE26B8224Q33559181-917ED588-1374-4EF5-AB4B-E9D8B6CCAB4CQ34555811-FD53614E-D876-4283-BDF3-0D3B630E3520Q34609746-5660347E-F8F7-45E7-A295-A1E85F32AB77Q35092790-EF60470B-8B00-4275-BD65-C28347C9DDECQ35569905-F79C8FB2-DC42-4F31-B227-15B42001E3BDQ35761217-A0974502-0DA6-4D52-AB17-33C87EEDD653Q35836695-A069D1BF-7BFB-4840-BC45-BCFA85DCA5F9Q36062835-5B8957BA-3C54-43D6-877A-452A9A167942Q36296995-FEA43C14-5C58-40E2-8A61-6D7773679D65Q36309506-73183E0F-1F17-4F89-8F33-3F7A646E6E7FQ36522913-A99948EB-84F6-4956-A84D-8534427611EDQ36642527-2768D2B2-C128-4B40-BF1B-6DAFCEAC944DQ36698786-48CEE75E-72D5-420F-A40B-2C2733AFC5B1Q36710889-C3335F7F-273F-49A8-B72E-0DF395425940Q36982054-B76B29C8-897F-4D14-A763-68D496F43EA0Q37095261-F756C1A1-85B0-4733-9075-D150C5663D08Q37259782-0C70CC01-814F-4D0A-93B4-E58ED83327F3Q37308566-E4E62892-C339-4925-8D93-5D63F4EE6A73Q37457219-5540EE5D-CC48-425A-B886-C7C167C66A49Q37559869-3A01B967-DDE6-4AD0-BF5D-EF31F34FB831Q37629444-A7243AD6-CCC6-426E-83CA-E42E56DC3614Q37680902-348EBEA6-29CF-4A8B-B5A6-449492D7C34EQ37781315-F322C602-FB08-4111-8363-C79EF3413CA0Q37968876-7790183F-9D31-4069-A764-A4ED57BADAF0Q38265533-2A900E8A-CF9C-4EAB-9CC3-763F9C50B88CQ38460376-005B2C38-71BF-4AD9-AAC7-D2CDF4EA02ADQ38510131-482F2A0D-D400-4D9F-BA04-65FDFA8DE3B0Q38565474-96B2ACD7-C5D6-47F4-8689-B2B75B8A7927Q38772847-FBD3207A-DAB6-4E52-A55A-F279899201A5Q39009998-8EE27F00-F3A4-42F6-B773-6B54D5CD0522Q39212748-8987E32B-44F7-4D5F-8B19-F43DC069AC23Q39376100-9C3E11F7-49E1-4E41-A87E-0D870313BE94Q39562918-CC5B51C9-9600-4495-A313-B3B525806ECDQ39877230-6FF99A62-9F08-41D6-A4D1-29EFA6372795
P2860
Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Tumor necrosis factor-induced ...... in light chain kinase promoter
@ast
Tumor necrosis factor-induced ...... in light chain kinase promoter
@en
Tumor necrosis factor-induced ...... in light chain kinase promoter
@nl
type
label
Tumor necrosis factor-induced ...... in light chain kinase promoter
@ast
Tumor necrosis factor-induced ...... in light chain kinase promoter
@en
Tumor necrosis factor-induced ...... in light chain kinase promoter
@nl
prefLabel
Tumor necrosis factor-induced ...... in light chain kinase promoter
@ast
Tumor necrosis factor-induced ...... in light chain kinase promoter
@en
Tumor necrosis factor-induced ...... in light chain kinase promoter
@nl
P2093
P3181
P356
P1476
Tumor necrosis factor-induced ...... in light chain kinase promoter
@en
P2093
Anning Lin
Fengjun Wang
Jason X Cheng
Jerrold R Turner
Yingmin Wang
P304
26205-26215
P3181
P356
10.1074/JBC.M602164200
P407
P577
2006-07-11T00:00:00Z